Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases

Biochimie

Volumn 73, Issue 10, 1991, Pages 1335-1338

  Calmus, Y ^a   Poupon, R ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

bile acids; cholestasis; major histocompatibility complex; primary biliary cirrhosis; ursodeoxycholic acid

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; PLACEBO; URSODEOXYCHOLIC ACID;

ARTICLE; CHOLESTASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNITY; LIVER CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ANIMAL; CHOLESTASIS; CHRONIC DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN; IN VITRO; LIVER CIRRHOSIS, BILIARY; MAJOR HISTOCOMPATIBILITY COMPLEX; URSODEOXYCHOLIC ACID;

EID: 0025983730     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/0300-9084(91)90098-L     Document Type: Article

References (22)

1. Primary biliary cirrhosis
2. Efficacy of liver transplantation in patients with primary biliary cirrhosis
3. Medical treatment of primary biliary cirrhosis
4. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
5. Hepatic injury induced by bile salts: correlation between biochemical and morphological events
6. Ursodeoxycholate reduces hepatoxicity of bile salts in primary human hepatocytes
7. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salt
8. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man
9. Ursodeoxycholic acid for the treatment of primary biliary corrhosis
10. A multicenter double blind trial of ursodiol for the treatment of primary biliary cirrhosis
11. Prognosis in primary biliary cirrhosos: model for decision making
12. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes
13. Distribution of the major histocompatibility complex antigens on different cellular components of human liver
14. Expression of blood group antigens including HLA markers in human adult liver
15. HLA-A, B, C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease
16. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
17. Hepatic ß2-microglobulin distribution in primary biliary cirrhosis
18. The role of gene products of the major histocompatibility complex in T cellactivation and cellular interactions
19. Expression hépatique des molécules du complexe majeur d'histocompatibilité
20. Increased expression of major histocompatibility antigens in the liver as a result of cholestasis
21. Cholestasis induces abnormal and aberrant HLA expression in the human liver
22. Quantitation and modulation of major histocompatibility complex (MHC) expression The effect of cholestasis and immunosuppressive drugs